Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Bucolo

Showing results (91-100 of 201) with videos related to

Pageof 21
Sort By:
Frontiers in Pharmacology|May 24, 2021
Attenuation of High Glucose-Induced Damage in RPE Cells through p38 MAPK Signaling Pathway InhibitionGrazia Maugeri, Claudio Bucolo, Filippo Drago, et al.
Biochemical Pharmacology|October 1, 2013
Role of phospholipases A2 in diabetic retinopathy: in vitro and in vivo studiesGabriella Lupo, Carla Motta, Giovanni Giurdanella, et al.
International Journal of Pharmaceutics|May 6, 2014
Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticlesAntonio Leonardi, Claudio Bucolo, Giovanni Luca Romano, et al.
Current Opinion in Pharmacology|January 6, 2024
Integrating network pharmacology: The next-generation approach in ocular drug discoveryFrancesca Lazzara, Federica Conti, Erika Giuffrida, et al.
Frontiers in Pharmacology|March 30, 2026
Selective phosphoinositide 3-kinase inhibitors and implication in diabetic retinopathy as pharmacological toolsCarmela Bonaccorso, Francesca Lazzara, Isabel La Rosa, et al.
Biochemical Pharmacology|August 6, 2008
Contribution of alpha4beta1 integrin to the antiallergic effect of levocabastineAhmed R Qasem, Claudio Bucolo, Monica Baiula, et al.
The International Journal of Neuropsychopharmacology|June 15, 2012
Behavioural and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutantAlessandra Tamburella, Gian Marco Leggio, Vincenzo Micale, et al.
Journal of Molecular Neuroscience : MN|February 4, 2014
Davunetide (NAP) protects the retina against early diabetic injury by reducing apoptotic deathSoraya Scuderi, Agata Grazia D'Amico, Alessandro Castorina, et al.
Journal of Molecular Neuroscience : MN|February 14, 2015
Different Retinal Expression Patterns of IL-1α, IL-1β, and Their Receptors in a Rat Model of Type 1 STZ-Induced DiabetesSoraya Scuderi, Agata Grazia D'amico, Concetta Federico, et al.
Frontiers in Pharmacology|September 7, 2021
Short-and Long-Term Expression of Vegf: A Temporal Regulation of a Key Factor in Diabetic RetinopathyClaudio Bucolo, Annalisa Barbieri, Ilaria Viganò, et al.
Pageof 21

Showing results (91-100 of 201) with videos related to

Sort By:
Pageof 21
Frontiers in Pharmacology|May 24, 2021
Attenuation of High Glucose-Induced Damage in RPE Cells through p38 MAPK Signaling Pathway InhibitionGrazia Maugeri, Claudio Bucolo, Filippo Drago, et al.
Biochemical Pharmacology|October 1, 2013
Role of phospholipases A2 in diabetic retinopathy: in vitro and in vivo studiesGabriella Lupo, Carla Motta, Giovanni Giurdanella, et al.
International Journal of Pharmaceutics|May 6, 2014
Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticlesAntonio Leonardi, Claudio Bucolo, Giovanni Luca Romano, et al.
Current Opinion in Pharmacology|January 6, 2024
Integrating network pharmacology: The next-generation approach in ocular drug discoveryFrancesca Lazzara, Federica Conti, Erika Giuffrida, et al.
Frontiers in Pharmacology|March 30, 2026
Selective phosphoinositide 3-kinase inhibitors and implication in diabetic retinopathy as pharmacological toolsCarmela Bonaccorso, Francesca Lazzara, Isabel La Rosa, et al.
Biochemical Pharmacology|August 6, 2008
Contribution of alpha4beta1 integrin to the antiallergic effect of levocabastineAhmed R Qasem, Claudio Bucolo, Monica Baiula, et al.
The International Journal of Neuropsychopharmacology|June 15, 2012
Behavioural and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutantAlessandra Tamburella, Gian Marco Leggio, Vincenzo Micale, et al.
Journal of Molecular Neuroscience : MN|February 4, 2014
Davunetide (NAP) protects the retina against early diabetic injury by reducing apoptotic deathSoraya Scuderi, Agata Grazia D'Amico, Alessandro Castorina, et al.
Journal of Molecular Neuroscience : MN|February 14, 2015
Different Retinal Expression Patterns of IL-1α, IL-1β, and Their Receptors in a Rat Model of Type 1 STZ-Induced DiabetesSoraya Scuderi, Agata Grazia D'amico, Concetta Federico, et al.
Frontiers in Pharmacology|September 7, 2021
Short-and Long-Term Expression of Vegf: A Temporal Regulation of a Key Factor in Diabetic RetinopathyClaudio Bucolo, Annalisa Barbieri, Ilaria Viganò, et al.
Pageof 21